Shin Miura

Dr. Shin Miura

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
SMShin Miura
Shin Miura
TTTetsuya Takikawa
Tetsuya Takikawa
KKKazuhiro Kikuta
Kazuhiro Kikuta
SHShin Hamada
Shin Hamada
KKKiyoshi Kume
Kiyoshi Kume
Atsushi MasamuneAtsushi Masamune
Atsushi Masamune
Pancreatic ductal adenocarcinoma (PDAC) accounts for the majority of all pancreatic cancers and is highly lethal. Focal parenchymal atrophy (FPA) of the pancreas has been reported as a characteristic imaging finding of early PDAC. Here, we reviewed 76 patients with PDAC who underwent computed tomography (CT) between 6 months and 3 years before PDAC diagnosis, as well as 76 sex- and age-matched controls without PDAC on CT examinations separated by at least 5 years. FPA was observed corresponding to the location of the subsequent tumor on pre-diagnostic CT in 14/44 (31.8%) patients between 6 months and 1 year, 14/51 (27.5%) patients between 1 and 2 years, and 9/41 (22.0%) patients between 2 and 3 years before PDAC diagnosis. Overall, FPA was more frequently observed in patients with PDAC (26/76; 34.2%) on pre-diagnostic CT than that in controls (3/76; 3.9%) (p < 0.001). FPA was observed before the appearance of cut-off/dilatation of the main pancreatic duct, suggesting that FPA might be the earliest sign of PDAC. FPA was less frequently found in tumors in the pancreatic head (3/27; 11.1%) than in those in the body (14/30; 46.7%) or tail (9/19; 47.4%). FPA may predict the subsequent PDAC diagnosis, serving as an important imaging sign for the early diagnosis of pancreatic cancer.

6 January 2024 in Pancreatology
Verified
Journal Article
Closed access
RMRyotaro Matsumoto
Ryotaro Matsumoto
KKKazuhiro Kikuta
Kazuhiro Kikuta
TTTetsuya Takikawa
Tetsuya Takikawa
TSTakanori Sano
Takanori Sano
SHShin Hamada
Shin Hamada
Atsushi MasamuneAtsushi Masamune
Atsushi Masamune

14 November 2023 in Digestive Endoscopy
Verified
Journal Article
Closed access
HIHirotoshi Ishiwatari
Hirotoshi Ishiwatari
TKTakanori Kawabata
Takanori Kawabata
HKHiroki Kawashima
Hiroki Kawashima
YNYousuke Nakai
Yousuke Nakai
SMShin Miura
Shin Miura
NSNaoki Sasahira
Naoki Sasahira

6 May 2019 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
SMShin Miura
Shin Miura
AKAtsushi Kanno
Atsushi Kanno
KFKoji Fukase
Koji Fukase
YTYu Tanaka
Yu Tanaka
RMRyotaro Matsumoto
Ryotaro Matsumoto
Atsushi MasamuneAtsushi Masamune
Atsushi Masamune

1 April 2020 in Internal Medicine
Verified
Journal Article
Open access
PDF file
RMRyotaro Matsumoto
Ryotaro Matsumoto
SMShin Miura
Shin Miura
AKAtsushi Kanno
Atsushi Kanno
MIMio Ikeda
Mio Ikeda
TSTakanori Sano
Takanori Sano
AMAtsushi Masamune
Atsushi Masamune
A 58-year-old man was referred for obstructive jaundice. Imaging modalities revealed the presence of multiple pancreatic tumors and the stenosis of the middle common bile duct due to a hypoenhanced localized tumor. The multiple pancreatic tumors were histopathologically diagnosed as autoimmune pancreatitis by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA). To differentiate between IgG4-related sclerosing cholangitis (IgG4-SC) and cholangiocarcinoma, we diagnosed the biliary tumor as IgG4-SC by EUS-FNA because of insufficient pathological materials obtained in a transpapillary manner. We herein report a case of IgG4-SC diagnosed by EUS-FNA.

12 October 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
HHHidehiro Hayashi
Hidehiro Hayashi
SMShin Miura
Shin Miura
FFFumiyoshi Fujishima
Fumiyoshi Fujishima
SKShimpei Kuniyoshi
Shimpei Kuniyoshi
KKKiyoshi Kume
Kiyoshi Kume
Atsushi MasamuneAtsushi Masamune
Atsushi Masamune
In Japan, type 1 autoimmune pancreatitis (AIP) is the most common type of AIP; type 2 AIP is rare. The aim of this study was to clarify the usefulness of endoscopic ultrasound-guided fine-needle aspiration and biopsy (EUS-FNAB) for the diagnosis of type 2 AIP. We analyzed the tissue specimens of 10 patients with suspected type 2 AIP who underwent EUS-FNAB at our hospital between April 2009 and March 2021 for tissue volume and histopathological diagnostic performance. The male-to-female ratio of the patients was 8:2, and the patient age (mean ± standard deviation) was 35.6 ± 15.5 years. EUS-FNAB provided sufficient tissue volume, with high-power field >10 in eight patients (80.0%). Based on the International Consensus Diagnostic Criteria (ICDC), four patients (40.0%) had histological findings corresponding to ICDC level 1, and five patients (50.0%) had histological findings corresponding to ICDC level 2. The results of this study show that EUS-FNB can be considered an alternative method to resection and core-needle biopsy for the collection of tissue samples of type 2 AIP.